PUBLISHER: Grand View Research | PRODUCT CODE: 1772208
PUBLISHER: Grand View Research | PRODUCT CODE: 1772208
U.S. Artificial Ventilation And Anesthesia Masks Market Size, Share & Trends Analysis Report By Mask Type (Disposable Masks, Reusable Masks), By Application (Operating Rooms, ICU, Emergency Rooms, Homecare, ASCs), And Segment Forecasts, 2025 - 2030
U.S. Artificial Ventilation And Anesthesia Masks Market Size & Trends:
The U.S. artificial ventilation and anesthesia masks market size was estimated at USD 552.7 million in 2024 and is projected to grow at a CAGR of 4.7% from 2025 to 2030. The growth can be attributed to the rising incidences of respiratory diseases, development in technology, rising number of surgeries, population growth, especially of the geriatric people, effects of the covid-19 pandemic, increased healthcare spending, and support in the policies.
The rising prevalence of chronic respiratory diseases such as COPD, asthma, and pneumonia will drive market growth. According to the CDC report of June 2024, around 6 million adults in the U.S. have COPD, and it is one of the top 10 causes of death in the U.S., presenting a significant opportunity for healthcare providers and manufacturers to invest in respiratory care solutions. The increasing demand for long-term home care and emergency treatment for lung diseases in adults and children will also contribute to market demand.
Advancements in technology have led to the development of more user-friendly and efficient artificial ventilation and anesthesia masks. Features such as integrated monitoring systems for disposables, improved mask designs for enhanced patient comfort, and enhanced safety features are attracting healthcare providers to these products. Moreover, as the demand for high-quality respiratory care solutions increases, manufacturers are investing in research and development to create innovative products that meet the evolving needs of healthcare professionals. With a focus on patient comfort, safety, and efficacy, the artificial ventilation and anesthesia masks market is poised for significant growth in the coming years.
The COVID-19 pandemic greatly impacted the U.S. artificial ventilation and anesthesia masks market, driving a surge in demand for respiratory support equipment due to the high incidence of severe respiratory complications. Hospitals and emergency departments faced acute shortages of ventilators and associated consumables, including masks, prompting rapid production scale-ups and emergency use authorizations by the FDA. The crisis accelerated the adoption of single-use and disposable masks to reduce cross-contamination risks and spurred innovations in non-invasive ventilation technologies. Additionally, supply chain disruptions and raw material shortages exposed vulnerabilities, leading to increased domestic manufacturing initiatives and stockpiling strategies post-pandemic.
U.S. Artificial Ventilation And Anesthesia Masks Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. artificial ventilation and anesthesia masks market report based on mask type and application:
- Mask Type Outlook (Revenue, USD Million, 2018 - 2030)
- Disposable Masks
- Reusable Masks
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Operating Rooms
- ICU
- Emergency Rooms
- Home Care
- ASCs
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing number of surgical procedures across hospitals and ambulatory centers
- 3.2.1.2. Growing prevalence of respiratory disorders
- 3.2.1.3. Technological advancements in mask materials, ergonomics, and integration with monitoring systems are enhancing product safety and comfort.
- 3.2.1.4. Increased focus on patient safety and infection control
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Availability of alternative solutions
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenges Analysis
- 3.2.1. Market Driver Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal landscape
- 3.3.3. Pricing Analysis
- 3.3.4. Impact of COVID 19
- 3.3.1. Porter's Five Forces Analysis
Chapter 4. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Type Movement Analysis, USD Million, 2024 & 2030
- 4.3. Disposable Masks
- 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Reusable Masks
- 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Artificial Ventilation and Anesthesia Masks Market: Application Movement Analysis, 2024 & 2030
- 5.3. Operating Rooms
- 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. ICU
- 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Emergency Rooms
- 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Homecare
- 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. ASCs
- 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Participant Overview
- 6.2. Company Market Position/Share Analysis, 2024
- 6.3. Company Categorization
- 6.4. Company Profiles/Listing
- 6.4.1. Medtronic
- 6.4.1.1. Overview
- 6.4.1.2. Financial performance
- 6.4.1.3. Product benchmarking
- 6.4.1.4. Strategic initiatives
- 6.4.2. BD (Becton, Dickinson and Company)
- 6.4.2.1. Overview
- 6.4.2.2. Financial performance
- 6.4.2.3. Product benchmarking
- 6.4.2.4. Strategic initiatives
- 6.4.3. ResMed
- 6.4.3.1. Overview
- 6.4.3.2. Financial performance
- 6.4.3.3. Product benchmarking
- 6.4.3.4. Strategic initiatives
- 6.4.4. Vyaire Medical, Inc.
- 6.4.4.1. Overview
- 6.4.4.2. Financial performance
- 6.4.4.3. Product benchmarking
- 6.4.4.4. Strategic initiatives
- 6.4.5. Dragerwerk AG & Co. KGaA
- 6.4.5.1. Overview
- 6.4.5.2. Financial performance
- 6.4.5.3. Product benchmarking
- 6.4.5.4. Strategic initiatives
- 6.4.6. Koninklijke Philips N.V.
- 6.4.6.1. Overview
- 6.4.6.2. Financial performance
- 6.4.6.3. Product benchmarking
- 6.4.6.4. Strategic initiatives
- 6.4.7. Nihon Kohden Corporation
- 6.4.7.1. Overview
- 6.4.7.2. Financial performance
- 6.4.7.3. Product benchmarking
- 6.4.7.4. Strategic initiatives
- 6.4.8. Hamilton Medical
- 6.4.8.1. Overview
- 6.4.8.2. Financial performance
- 6.4.8.3. Product benchmarking
- 6.4.8.4. Strategic initiatives
- 6.4.9. IBM
- 6.4.9.1. Overview
- 6.4.9.2. Financial performance
- 6.4.9.3. Product benchmarking
- 6.4.9.4. Strategic initiatives
- 6.4.10. Ambu A/S
- 6.4.10.1. Overview
- 6.4.10.2. Financial performance
- 6.4.10.3. Product benchmarking
- 6.4.10.4. Strategic initiatives
- 6.4.11. Cardinal Health
- 6.4.11.1. Overview
- 6.4.11.2. Financial performance
- 6.4.11.3. Product benchmarking
- 6.4.11.4. Strategic initiatives
- 6.4.1. Medtronic
List of Tables
- Table 1 List of secondary sources
- Table 2 List of abbreviations
- Table 3 U.S. artificial ventilation and anesthesia masks market, Type, 2018 - 2030 (USD Million)
- Table 4 U.S. artificial ventilation and anesthesia masks market, by Application, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Value chain-based sizing & forecasting
- Fig. 6 Market formulation & validation
- Fig. 7 Market segmentation
- Fig. 8 Market snapshot
- Fig. 9 Segment snapshot
- Fig. 10 Competitive landscape snapshot
- Fig. 11 Market trends & outlook
- Fig. 12 Market driver relevance analysis (current & future impact)
- Fig. 13 Market restraint relevance analysis (current & future impact)
- Fig. 14 PESTLE analysis
- Fig. 15 Porter's five forces analysis
- Fig. 16 U.S. artificial ventilation and anesthesia masks market Type Outlook: Key Takeaways
- Fig. 17 U.S. artificial ventilation and anesthesia masks market: type movement analysis, 2018 & 2030
- Fig. 18 Disposable masks market estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 19 Reusable masks market estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 20 U.S. artificial ventilation and anesthesia masks market application outlook: Key takeaways
- Fig. 21 U.S. artificial ventilation and anesthesia masks market: application movement analysis, 2018 & 2030 (USD Million)
- Fig. 22 Operating Rooms market estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 23 ICU market estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 24 Emergency rooms market estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 25 Home care market estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 26 ASCs market estimates and forecasts 2018 - 2030 (USD Million)
- Fig. 27 Market Participant Categorization
- Fig. 28 Strategy mapping
- Fig. 29 Company market position analysis
